[Trabeculectomy with Ologen ® implant and bevacizumab].

CONCLUSION: The highest success rate was achieved in group 1 with MMC but without an Ologen® implant or bevacizumab. In this study the additional use of Ologen® implants and bevacizumab in trabeculectomy was found to be a safe operation method but did not provide any additional benefits. PMID: 31541288 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31541288?dopt=Abstract

Source: Der Ophthalmologe - September 19, 2019 Category: Opthalmology Authors: Glandorf K, Lommatzsch C, Heinz C, Koch JM Tags: Ophthalmologe Source Type: research

More News: Avastin | Glaucoma | Opthalmology | Study